Skip to main content
iScience logoLink to iScience
. 2022 Jan 5;25(1):103713. doi: 10.1016/j.isci.2021.103713

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade

Naoki Hama, Takuto Kobayashi, Nanumi Han, Fumihito Kitagawa, Nabeel Kajihara, Ryo Otsuka, Haruka Wada, Hee-kyung Lee, Hwanseok Rhee, Yoshinori Hasegawa, Hideo Yagita, Muhammad Baghdadi, Ken-ichiro Seino
PMCID: PMC8741421  PMID: 35028541

Main Text

(iScience, 23, 101584-1–101584-11, October 23, 2020)

During the preparation of the key resources table, the wrong clone number was indicated for “purified anti-human IL-34.” The correct clone number is E033B8. This is corrected in the below supplemental information. The authors apologize for any confusion created to the readers.

Footnotes

Supplemental information can be found online at https://doi.org/10.1016/j.isci.2021.103713.

Supplemental Information

Document S1. Transparent Methods and Figures S1–S5
mmc1.pdf (892.4KB, pdf)

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Transparent Methods and Figures S1–S5
mmc1.pdf (892.4KB, pdf)

Articles from iScience are provided here courtesy of Elsevier

RESOURCES